Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT03739164Unknown

Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)

Role: lead

NCT03607435Not ApplicableUnknown

A Clinical Study to Collect Calibration & Performance Data of the KBS Systems 1.0 Non-Invasive Glucose Monitoring Device

Role: lead

NCT02575014Not ApplicableUnknown

Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen Therapy

Role: lead

NCT03247257Not ApplicableUnknown

Comparing Epidural Versus General Anesthesia for LESS Cholecystectomies

Role: lead

NCT02823678Unknown

Pancreas Volume and Diabetes Status Following Pancreatectomy

Role: lead

NCT02264444Not ApplicableCompleted

Establishing Visualization Grading Scale on LESS Cholecystectomy

Role: lead

NCT02065661Completed

Product Validation Study of 2 New Devices, EZ-NG (RightSpot pH Indicator) and EZ-pH (RightLevel pH Indicator)

Role: lead

All 7 trials loaded